Efficacy of vitamin D supplementation and metformin compared to metformin alone in infertile females with polycystic ovary syndrome: a randomized open label trial.
Preprint
- 19 May 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: WHO has declared Infertility as the fifth-highest serious global disability with prevalence of approximately 22% in Pakistan; 80% due to polycystic ovarian syndrome (PCOS). PCOS is characterized by “the presence of any two out of three criteria, that is oligo and/or anovulation, excess androgen activity and/or polycystic ovarian morphology on ultrasound”. Vitamin D deficiency (VDD) [serum 25(OH) D <20 ng/ml] is vital for female health and becoming public health problem even in sun-drenched cities. With high prevalence (58%) of VDD in Pakistani PCOS. The hypothesis: “VD supplementation can improve fertility by correcting in IR, ovulatory dysfunction, endometrial thickness and hyperandrogenism in primary infertile PCOS patients of our population”. We aim to evaluate impact of oral VD supplementation on fertility potential of VDD PCOS (VD <20 ng/ml) in a 2-years randomized clinical trial; Group-1 VDD control PCOS (n=100) and Group-2 VDD intervention group (n=100). Group-1will receive 1.5 g/day metformin therapy for 24 weeks. Group-2 will be given 50,000 I.U of VD once weekly for 8 weeks, followed by 50,000 I.U once every fortnight from 9- 24 weeks plus metformin therapy. Impact will be assessed by comparing trans-vaginal ultrasound (TVS; Day 12) at the start with TVS at end point (24 weeks) to observe change in dominantfollicle size (≥14 mm) and endometrial thickness (≥8 mm). Discussion: The proposed interventions will help to evaluate the impact of vitamin D supplementation on follicular maturation and endometrial thickness and PCOS parameters including lipid index and insulin resistance. Trial registration: ClinicalTrials.gov, NCT03989778Keywords
This publication has 33 references indexed in Scilit:
- Vitamin D deficiency effects on cardiovascular parameters in women with polycystic ovary syndrome: A retrospective, cross-sectional studyThe Journal of Steroid Biochemistry and Molecular Biology, 2021
- Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trialClinical Nutrition, 2021
- The efficacy of vitamin D combined with clomiphene citrate in ovulation induction in overweight women with polycystic ovary syndrome: a double blind, randomized clinical trialEndocrine, 2020
- Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trialEuropean Journal of Nutrition, 2018
- Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trialsComplementary Therapies in Clinical Practice, 2017
- The relationship of serum 25-dihydroxy vitamin D3 concentrations with metabolic parameters in non-obese women with polycystic ovarian syndromeMiddle East Fertility Society Journal, 2016
- The D-Health Trial: A randomized trial of vitamin D for prevention of mortality and cancerContemporary Clinical Trials, 2016
- Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndromeClinical Nutrition, 2015
- Vitamin D improves endometrial thickness in PCOS women who need intrauterine insemination: a randomized double-blind placebo-controlled trialArchives of Gynecology and Obstetrics, 2013
- Effect of 25-hydroxyvitamin D on metabolic parameters and insulin resistance in patients with polycystic ovarian syndromeMiddle East Fertility Society Journal, 2012